Interestingly our data confirm in all BRAF mutated melanoma cell lines analysed that FOXD3 mRNA is upregulated, however it never precedes temporally upregulation of NRG1, which, to our opinion, remains therefore the principal driver of adaptive resistance to BRAF and MEK inhibitors. This evidence concerns the gene MAP2K7 and melanoma.